EUB-18341-07770
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 359 / AL
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Moderna
- 2020-12-29
- 2020-12-30
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-01
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-02
- 2021-01-03
- 2021-01-05
- 2021-01-21
-
2021-01-26
Dose 2 — Moderna
-
2021-02-02
Health check-in — day 7, dose 2Feeling: Good · Site: Pain, Redness · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-09
- 2021-02-16
-
2021-02-23
Survey response — day 28, dose 2MedDRA: Rash erythematous — Feeling: GoodFree text: I broke out with red areas and a rash I actually have 4 different places on my bodyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-02
- 2021-03-09
- 2021-04-29
- 2021-07-27
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-27
- 2022-01-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Moderna | |
| 2 | 2021-01-26 | Moderna |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 4 — day 28, dose 2
Symptoms: I broke out with red areas and a rash I actually have 4 different places on my body
Release 11 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release